Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[14C]Navlimetostat Mass Balance Study in Healthy Female Participants
NL-OMON61639Phase 1Recruiting
- Sponsor
- Bristol Myers Squibb
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of navlimetostat, sponsored by Bristol Myers Squibb. Started Sep 2026; status: recruiting.
02
Drugs
navlimetostat
Beyond the preview
Go deeper on NL-OMON61639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON61639.